BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Prognosis
103 results:

  • 1. Radiofrequency Ablation for colorectal cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival.
    Akhan O; Akçalar S; Ünal E; Metin Y; Çiftçi T; Akıncı D
    Turk J Gastroenterol; 2023 Jun; 34(6):645-651. PubMed ID: 37232461
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Surgical outcomes of left hemicolon sparing resection versus extensive resection in treating synchronous colorectal cancer involving the right-sided colon and sigmoid colon or rectum.
    Quan J; Liu J; Zhou S; Mei S; Qiu W; Wan Y; Wang X; Tang J
    World J Surg Oncol; 2023 Apr; 21(1):131. PubMed ID: 37055785
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
    Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment.
    Luo H; Xia X; Huang LB; An H; Cao M; Kim GD; Chen HN; Zhang WH; Shu Y; Kong X; Ren Z; Li PH; Liu Y; Tang H; Sun R; Li C; Bai B; Jia W; Liu Y; Zhang W; Yang L; Peng Y; Dai L; Hu H; Jiang Y; Hu Y; Zhu J; Jiang H; Li Z; Caulin C; Park J; Xu H
    Nat Commun; 2022 Nov; 13(1):6619. PubMed ID: 36333338
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Analysis of survival and clinicopathological characteristics in patients after liver resection for colorectal liver metastases according to resection margin.
    Casas-Sicilia E; Jiménez-Bernadó A; Jaime-Sánchez A; Gracia-Solanas JA; Palacios-Gasos P; Borrego-Estella VM
    Cir Cir; 2022; 90(S1):96-107. PubMed ID: 35944108
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk stratification for predicting postoperative recurrence/metastasis of colorectal cancer by grade of venous invasion coupled with histological subtype.
    Imai Y; Ichinose M
    BMC Gastroenterol; 2022 Feb; 22(1):79. PubMed ID: 35197005
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype.
    Deng J; Tian AL; Pan H; Sauvat A; Leduc M; Liu P; Zhao L; Zhang S; Chen H; Taly V; Laurent-Puig P; Senovilla L; Li Y; Kroemer G; Kepp O
    Cell Death Dis; 2021 Oct; 12(11):978. PubMed ID: 34675191
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Low anterior resection syndrome-Causes and treatment approaches].
    Stelzner S; Kupsch J; Mees ST
    Chirurg; 2021 Jul; 92(7):612-620. PubMed ID: 33877394
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [The influence of XRCC1 gene polymorphism on the prognosis and safety of stage Ⅲ patients with colorectal cancer who received oxaliplatin based adjuvant chemotherapy].
    Li RX; Shang JH; Sun JF
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):759-765. PubMed ID: 33765714
    [No Abstract]    [Full Text] [Related]  

  • 10. Enhanced recovery after surgery nursing program, a protective factor for stoma-related complications in patients with low rectal cancer.
    Shao W; Wang H; Chen Q; Zhao W; Gu Y; Feng G
    BMC Surg; 2020 Dec; 20(1):316. PubMed ID: 33276751
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetic Variants in the Regulatory T cell-Related Pathway and colorectal cancer prognosis.
    Neumeyer S; Hua X; Seibold P; Jansen L; Benner A; Burwinkel B; Halama N; Berndt SI; Phipps AI; Sakoda LC; Schoen RE; Slattery ML; Chan AT; Gala M; Joshi AD; Ogino S; Song M; Herpel E; Bläker H; Kloor M; Scherer D; Ulrich A; Ulrich CM; Win AK; Figueiredo JC; Hopper JL; Macrae F; Milne RL; Giles GG; Buchanan DD; Peters U; Hoffmeister M; Brenner H; Newcomb PA; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2719-2728. PubMed ID: 33008876
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Telomere Maintenance Variants and Survival after colorectal cancer: Smoking- and Sex-Specific Associations.
    Yin H; Hardikar S; Lindstroem S; Hsu L; Anderson KE; Banbury BL; Berndt SI; Chan AT; Giovanucci EL; Harrison TA; Joshi AD; Nan H; Potter JD; Sakoda LC; Slattery ML; Schoen RE; White E; Peters U; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1817-1824. PubMed ID: 32586834
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [The safety and efficacy of radical surgery after modified total neoadjuvant therapy for locally advanced rectal cancer].
    Zhang L; Yu L; Wu YL; Zhang QQ; Shen SH; Li DD; Fang H; Yang L; Zhang HZ
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):501-506. PubMed ID: 32575948
    [No Abstract]    [Full Text] [Related]  

  • 14. colorectal cancer with invasive micropapillary components (IMPCs) shows high lymph node metastasis and a poor prognosis: A retrospective clinical study.
    Guo Z; Yang Z; Li D; Tang J; Xu J; Shen H; Yuan Y
    Medicine (Baltimore); 2020 May; 99(21):e20238. PubMed ID: 32481300
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The influence of PD-L1 genetic variation on the prognosis of R0 resection colorectal cancer patients received capecitabine-based adjuvant chemotherapy: a long-term follow-up, real-world retrospective study.
    Su J; Dai B; Yuan W; Wang G; Zhang Z; Li Z; Liu J; Song J
    Cancer Chemother Pharmacol; 2020 May; 85(5):969-978. PubMed ID: 32314029
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Separation of Low- Versus High-grade Crohn's Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis.
    Arpa G; Grillo F; Giuffrida P; Nesi G; Klersy C; Mescoli C; Lenti MV; Lobascio G; Martino M; Latella G; Malvi D; Macciomei MC; Fociani P; Villanacci V; Rizzo A; Ferrero S; Sessa F; Orlandi A; Monteleone G; Biancone L; Cantoro L; Tonelli F; Ciardi A; Poggioli G; Rizzello F; Ardizzone S; Sampietro G; Solina G; Oreggia B; Papi C; D'Incà R; Vecchi M; Caprioli F; Caronna R; D'Errico A; Fiocca R; Rugge M; Corazza GR; Luinetti O; Paulli M; Solcia E; Di Sabatino A; Vanoli A
    J Crohns Colitis; 2020 Mar; 14(3):295-302. PubMed ID: 31418007
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Major depression but not minor to intermediate depression correlates with unfavorable prognosis in surgical colorectal cancer patients underwent adjuvant chemotherapy.
    Xia S; Sun M; Liu X
    Psychol Health Med; 2020 Mar; 25(3):309-318. PubMed ID: 31397608
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [The impact of genetic variation of KDR on clinical outcomes of advanced colorectal cancer patients treated by first line bevacizumab based regimens].
    Wang HX; Mei X; Gong TX; Han N; Liu P; Wang J; Zhang ZM
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(34):2737-2742. PubMed ID: 30220171
    [No Abstract]    [Full Text] [Related]  

  • 19. [The influence of Thymidine Phosphorylase genetic variation on clinical outcomes and safety of colorectal cancer patients received adjuvant chemotherapy after R0 resection].
    Du YB; Zhang TF; Cui K; Jin SL; Xi Y; Ma W
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(32):2569-2573. PubMed ID: 30220141
    [No Abstract]    [Full Text] [Related]  

  • 20. Identification of Positively and Negatively Selected Driver Gene Mutations Associated With colorectal cancer With Microsatellite Instability.
    Jonchere V; Marisa L; Greene M; Virouleau A; Buhard O; Bertrand R; Svrcek M; Cervera P; Goloudina A; Guillerm E; Coulet F; Landman S; Ratovomanana T; Job S; Ayadi M; Elarouci N; Armenoult L; Merabtene F; Dumont S; Parc Y; Lefèvre JH; André T; Fléjou JF; Guilloux A; Collura A; de Reyniès A; Duval A
    Cell Mol Gastroenterol Hepatol; 2018; 6(3):277-300. PubMed ID: 30116770
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.